求文献，谢谢# Biology - 生物学
s*i
1 楼
在国内读了两年博士然后退学来的美国。请问简历中这两年应该怎么写比较好？写
doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
解成粗心大意忘记写所得学位？谢谢。
doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
解成粗心大意忘记写所得学位？谢谢。
g*d
2 楼
I ask for paper, due to unavailability of downloading in our hospital.
J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30110-3. doi: 10.
1016/j.healun.2016.04.007. [Epub ahead of print]
The effect of timing and graft dysfunction on survival and cardiac allograft
vasculopathy in antibody-mediated rejection.
Clerkin KJ1, Restaino SW1, Zorn E2, Vasilescu ER3, Marboe CC3, Mancini DM4.
Author information
Abstract
BACKGROUND:
Antibody-mediated rejection (AMR) has been associated with increased death
and cardiac allograft vasculopathy (CAV). Early studies suggested that late
AMR was rarely associated with graft dysfunction, whereas recent reports
have demonstrated an association with increased mortality. We investigated
the timing of AMR and its association with graft dysfunction, death, and CAV.
METHODS:
This retrospective cohort study identified all adult orthotopic heart
transplant (OHT) recipients (N = 689) at Columbia University Medical Center
from 2004 to 2013. There were 68 primary cases of AMR, which were stratified
by early (< 1 year post-OHT) or late (> 1 year post-OHT) AMR. Kaplan-Meier
survival analysis and modeling was performed with multivariable logistic
regression and Cox proportional hazards regression.
RESULTS:
From January 1, 2004, through October 1, 2015, early AMR (median 23 days
post-OHT) occurred in 43 patients and late AMR (median 1,084 days post-OHT)
occurred in 25. Graft dysfunction was less common with early compared with
late AMR (25.6% vs 56%, p = 0.01). Patients with late AMR had decreased post
-AMR survival compared with early AMR (1 year: 80% vs 93%, 5 years: 51% vs
73%, p < 0.05). When stratified by graft dysfunction, only those with late
AMR and graft dysfunction had worse survival (30 days: 79%, 1 year: 64%, 5
years: 36%; p < 0.006). The association remained irrespective of age, sex,
donor-specific antibodies, left ventricular assist device use, reason for
OHT, and recovery of graft function. Similarly, those with late AMR and
graft dysfunction had accelerated development of de novo CAV (50% at 1 year;
hazard ratio, 5.42; p = 0.009), whereas all other groups were all similar
to the general transplant population.
CONCLUSIONS:
Late AMR is frequently associated with graft dysfunction. When graft
dysfunction is present in late AMR, there is an early and sustained
increased risk of death and rapid development of de novo CAV despite
aggressive treatment.
my Email: [email protected]/* */
Thank you very much.
J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30110-3. doi: 10.
1016/j.healun.2016.04.007. [Epub ahead of print]
The effect of timing and graft dysfunction on survival and cardiac allograft
vasculopathy in antibody-mediated rejection.
Clerkin KJ1, Restaino SW1, Zorn E2, Vasilescu ER3, Marboe CC3, Mancini DM4.
Author information
Abstract
BACKGROUND:
Antibody-mediated rejection (AMR) has been associated with increased death
and cardiac allograft vasculopathy (CAV). Early studies suggested that late
AMR was rarely associated with graft dysfunction, whereas recent reports
have demonstrated an association with increased mortality. We investigated
the timing of AMR and its association with graft dysfunction, death, and CAV.
METHODS:
This retrospective cohort study identified all adult orthotopic heart
transplant (OHT) recipients (N = 689) at Columbia University Medical Center
from 2004 to 2013. There were 68 primary cases of AMR, which were stratified
by early (< 1 year post-OHT) or late (> 1 year post-OHT) AMR. Kaplan-Meier
survival analysis and modeling was performed with multivariable logistic
regression and Cox proportional hazards regression.
RESULTS:
From January 1, 2004, through October 1, 2015, early AMR (median 23 days
post-OHT) occurred in 43 patients and late AMR (median 1,084 days post-OHT)
occurred in 25. Graft dysfunction was less common with early compared with
late AMR (25.6% vs 56%, p = 0.01). Patients with late AMR had decreased post
-AMR survival compared with early AMR (1 year: 80% vs 93%, 5 years: 51% vs
73%, p < 0.05). When stratified by graft dysfunction, only those with late
AMR and graft dysfunction had worse survival (30 days: 79%, 1 year: 64%, 5
years: 36%; p < 0.006). The association remained irrespective of age, sex,
donor-specific antibodies, left ventricular assist device use, reason for
OHT, and recovery of graft function. Similarly, those with late AMR and
graft dysfunction had accelerated development of de novo CAV (50% at 1 year;
hazard ratio, 5.42; p = 0.009), whereas all other groups were all similar
to the general transplant population.
CONCLUSIONS:
Late AMR is frequently associated with graft dysfunction. When graft
dysfunction is present in late AMR, there is an early and sustained
increased risk of death and rapid development of de novo CAV despite
aggressive treatment.
my Email: [email protected]/* */
Thank you very much.
d*u
3 楼
research assistant for 2 yrs
【在 s******i 的大作中提到】
: 在国内读了两年博士然后退学来的美国。请问简历中这两年应该怎么写比较好？写
: doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
: 解成粗心大意忘记写所得学位？谢谢。
【在 s******i 的大作中提到】
: 在国内读了两年博士然后退学来的美国。请问简历中这两年应该怎么写比较好？写
: doctoral candidate，还是只写所在学校院系，忽略身份？第二个方案的话会不会被误
: 解成粗心大意忘记写所得学位？谢谢。
相关阅读
有了解西安交大前沿科学研究院的吗？ (转载)leon要走，索男也看不下去了OCT化了解剖出器官来whole mount immunostaining可行吗live/dead stain染细菌，不同机理的kit对damaged判断结果会差别很大吗RNA-seq 代替 real－time PCR？求个文献该怎么合作？Wendell Lim 牛文大家怎么拿到审稿机会的？拿不到的人求求求审稿就金钱而言，我远没有我的本科同学富足申请做reviewer是给editor-in-chief 写信么？两个包子求找faculty position推荐信的模板求paper。 感谢帮忙！293 CELL转发自水木，黑出翔了~~在读journal club，发现这几个图其实是一样的啊。。。怎么能查到FDA正在进行的某方向的clinical trials？请教TRE启动子是否严格？是否存在leaky expression？前途迷惘，真诚求建议有没有像Ingenuity Pathway Analysis 那样免费的画protein interaction图的软件？